Laila Wali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Laila Wali has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Amitkumar Sharma
Cardiology, Royal Liverpool University Hospital, Liverpool, UK
1 shared publication- Jennifer Pilling
Department of Cardiology, Royal Liverpool University Hospital , Mount Vernon St, Liverpool L7 8YE
1 shared publication Kai Neoh
Cardiology, Royal Liverpool University Hospital, Liverpool, UK
1 shared publicationKhaled Albouaini
Department of Cardiology, Royal Liverpool University Hospital , Mount Vernon St, Liverpool L7 8YE
1 shared publication- Mohammad Adeeb Abbara
Department of Cardiology, Royal Liverpool University Hospital , Mount Vernon St, Liverpool L7 8YE
1 shared publication Scott W Murray
Department of Cardiology, Royal Liverpool University Hospital , Mount Vernon St, Liverpool L7 8YE
1 shared publication
Latest Publications
- 24 June 2026
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 102 (1212) , 935-941
Diastolic dysfunction and diabetes: the DIADAD study—a retrospective cohort study from Liverpool
Background: Diastolic dysfunction is an important early indicator of heart failure (HF) with preserved ejection fraction (HFpEF). Type 2 diabetes mellitus (T2DM) may contribute to HFpEF, as it is associated with an increased risk of hospitalization and mortality. Aim: To investigate the association between diastolic dysfunction and T2DM in an adult population from Liverpool, accounting for age and sex. Methods: A retrospective review of 493 patient records was conducted, extracting data on diastolic function status, diabetes status, age, and sex. Echocardiographic parameters were used to assess and grade diastolic function according to the 2016 ASE/EACVI recommendations. Results: Diastolic dysfunction was more prevalent in type 2 diabetics (71.42%) than non-diabetic patients (43.98%) (P < .05). The odds ratio of developing diastolic dysfunction was 2.636 times higher in diabetics, with 2.56 times greater odds of a higher dysfunction grade (P < .001). Age ≥65 years was associated with 4.65 times higher odds of having diastolic dysfunction, with no significant difference between genders. Conclusions: This retrospective cohort study demonstrates a clear and statistically significant association between T2DM, advancing age and diastolic dysfunction. This association, however, should be interpreted within the context of a clinically selected population undergoing echocardiography. Due to the metabolic alterations that are associated with diabetes and the pathophysiology of HFpEF, there is a great potential for the use antidiabetic therapies as cardioprotective agents aimed at reducing HF morbidity and mortality. Considering these results, we propose incorporating diabetes into the H2FpEF score. Key messages What is already known on this topic – the development of heart failure with preserved ejection fraction (HFpEF) has long been associated with type 2 diabetes mellitus (T2DM), with the recognition of diastolic dysfunction as an early marker of disease progression. However, data describing the relationship between diabetes and diastolic dysfunction in specific local populations remains limited. What this study adds – this study provides data from a Liverpool tertiary centre showcasing significantly higher prevalence and severity of diastolic dysfunction in patients with type 2 diabetes. These findings produce locally relevant epidemiological evidence that supports the association between diabetes and diastolic dysfunction. How this study might affect research, practice or policy – the findings of this study highlight the importance of cardiovascular assessment in patients with type 2 diabetes in certain populations with a high burden of diabetes, such as Liverpool, and may support earlier identification of individuals at risk of developing HFpEF. Future research might consider incorporating T2DM into the H₂FPEF score, to improve early risk stratification.
- 24 June 2026
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 102 (1212) , 935-941
Diastolic dysfunction and diabetes: the DIADAD study—a retrospective cohort study from Liverpool
Background: Diastolic dysfunction is an important early indicator of heart failure (HF) with preserved ejection fraction (HFpEF). Type 2 diabetes mellitus (T2DM) may contribute to HFpEF, as it is associated with an increased risk of hospitalization and mortality. Aim: To investigate the association between diastolic dysfunction and T2DM in an adult population from Liverpool, accounting for age and sex. Methods: A retrospective review of 493 patient records was conducted, extracting data on diastolic function status, diabetes status, age, and sex. Echocardiographic parameters were used to assess and grade diastolic function according to the 2016 ASE/EACVI recommendations. Results: Diastolic dysfunction was more prevalent in type 2 diabetics (71.42%) than non-diabetic patients (43.98%) (P < .05). The odds ratio of developing diastolic dysfunction was 2.636 times higher in diabetics, with 2.56 times greater odds of a higher dysfunction grade (P < .001). Age ≥65 years was associated with 4.65 times higher odds of having diastolic dysfunction, with no significant difference between genders. Conclusions: This retrospective cohort study demonstrates a clear and statistically significant association between T2DM, advancing age and diastolic dysfunction. This association, however, should be interpreted within the context of a clinically selected population undergoing echocardiography. Due to the metabolic alterations that are associated with diabetes and the pathophysiology of HFpEF, there is a great potential for the use antidiabetic therapies as cardioprotective agents aimed at reducing HF morbidity and mortality. Considering these results, we propose incorporating diabetes into the H2FpEF score. Key messages What is already known on this topic – the development of heart failure with preserved ejection fraction (HFpEF) has long been associated with type 2 diabetes mellitus (T2DM), with the recognition of diastolic dysfunction as an early marker of disease progression. However, data describing the relationship between diabetes and diastolic dysfunction in specific local populations remains limited. What this study adds – this study provides data from a Liverpool tertiary centre showcasing significantly higher prevalence and severity of diastolic dysfunction in patients with type 2 diabetes. These findings produce locally relevant epidemiological evidence that supports the association between diabetes and diastolic dysfunction. How this study might affect research, practice or policy – the findings of this study highlight the importance of cardiovascular assessment in patients with type 2 diabetes in certain populations with a high burden of diabetes, such as Liverpool, and may support earlier identification of individuals at risk of developing HFpEF. Future research might consider incorporating T2DM into the H₂FPEF score, to improve early risk stratification.
- 28 May 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (5) , e269872
Ruptured right coronary artery bypass graft aneurysm causing haemothorax
A woman in her 80s with a background of a coronary artery bypass graft (CABG) presented with chest pain. Initial investigations revealed an elevated D-dimer, normocytic anaemia and right-sided pleural effusion. CT pulmonary angiogram ruled out a pulmonary embolism but revealed an incidental cyst-like rounded lesion next to the ascending aorta. A triphasic CT of the chest confirmed this to be an aneurysm arising from the right coronary artery bypass vein graft, measuring 5.4 cm. After the multidisciplinary team meeting discussion, the likely diagnosis was thought to be a ruptured aneurysm, leading to a haematoma formation and right-sided haemothorax. Conservative management was chosen following multidisciplinary discussion and shared decision-making with the patient and family, and patient unfortunately did not survive admission. This case highlights rare and life-threatening complication of vein graft aneurysms and the importance of early recognition and individualised management plans.
- 28 May 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (5) , e269872
Ruptured right coronary artery bypass graft aneurysm causing haemothorax
A woman in her 80s with a background of a coronary artery bypass graft (CABG) presented with chest pain. Initial investigations revealed an elevated D-dimer, normocytic anaemia and right-sided pleural effusion. CT pulmonary angiogram ruled out a pulmonary embolism but revealed an incidental cyst-like rounded lesion next to the ascending aorta. A triphasic CT of the chest confirmed this to be an aneurysm arising from the right coronary artery bypass vein graft, measuring 5.4 cm. After the multidisciplinary team meeting discussion, the likely diagnosis was thought to be a ruptured aneurysm, leading to a haematoma formation and right-sided haemothorax. Conservative management was chosen following multidisciplinary discussion and shared decision-making with the patient and family, and patient unfortunately did not survive admission. This case highlights rare and life-threatening complication of vein graft aneurysms and the importance of early recognition and individualised management plans.